Paola Marignani
Role: Scientist
Sites: CDL-Atlantic, CDL-Rockies, CDL-Toronto, CDL-Vancouver
Streams: Cancer, Prime
Dr. Paola Marignani is a Full Professor at Dalhousie University in the Faculty of Medicine, Dept. Biochemistry and Molecular Biology. She conducted postdoctoral training at the Lunenfeld-Tanenbaum Research Institute and the Ontario Cancer Institute, Toronto, Ontario and at Harvard Medical School in the Division of Signal Transduction. In addition to Dr. Marignani’s scientific expertise, she holds an Executive MBA from Ivey Business School and a certificate from MIT Sloan School of Management-Artificial Intelligence in Health Care. Dr. Marignani is the Founder and CEO of Single Cell Precision Inc.
Dr. Marignani is the Founder of Canadian Women in STEM that is focused on building a equity, diversity and inclusion in the Canadian research ecosystem.
Dr. Marignani serves on the IASLC Basic & Translational Science Committee and is a member of the AACR Lung Cancer Research Scientific Review Committee, AACR-Johnson & Johnson Interventional Oncology Stimulating Therapeutic Advances through Research Training (START) Committee, and the AACR-ALK Positive Lung Cancer Research Fellowships Committee. She is also Scientific Director of the QEII Lung Tumour Biobank.
Dr. Marignani is the recipient of the CDL-Atlantic Scientist of the Year award for 2025/2026.